Heartland Conference Sneak Peek: Valuing Market Expansion Opportunities

Published in Member Communities on April 04, 2022

Ryan BallLooking for growth next year? Your road to profitability can be accelerated by utilizing data to value opportunity: 

  • Define current and potential new market size by product category.
  • Quantify market share and competitive landscape.
  • Identify and value top potential referral source partners by category and area.
  • Determine top payers and key contracting partners in new market areas.
  • Compare reimbursement rate variance from current and new markets.

The HME market is changing, current market dynamics have further incentivized providers to explore new areas for growth and expansion. Planning for growth and selecting new markets is too often a guessing game. What is my market share in my current markets? How much business is in that new market and how does that compare to my current markets? Who are my competitors and which payers do they work with? What is reimbursement for the new product focus with private payers? Too often, HME providers move into a new market without having the answers they need.

Whether entering a new geographic market or expanding into a new product line, data should be at the heart of your business development strategy. Rather than flying blind into a new venture, hoping your projections will take hold, analyzing available market intelligence data can provide greater certainty to your strategic planning and jump-start efforts to grow your business.

At this year’s Heartland Conference, join VGM Market Data director, Ryan Ball to learn how data can enhance your market expansion planning efforts to ensure you’re selecting the right markets and setting your growth plan up for success in 2022 and beyond. Learn more and register at vgmheartland.com.


TAGS

  1. data
  2. heartland
  3. market data

From Our Experts

Simplify Your Reimbursement Process for the AffloVest thumbnail Simplify Your Reimbursement Process for the AffloVest To support clinicians, care teams, and payer partners, Tactile Medical has streamlined the process for determining medical necessity and documentation standards for the AffloVest. Simplify Your Reimbursement Process for the AffloVest thumbnail Simplify Your Reimbursement Process for the AffloVest To support clinicians, care teams, and payer partners, Tactile Medical has streamlined the process for determining medical necessity and documentation standards for the AffloVest. Matt Filippis Named Director of Business Development at VGM thumbnail Matt Filippis Named Director of Business Development at VGM VGM & Associates appoints Matt Filippis as Director of Business Development, Clinical Mobility and Accessibility, supporting CRT, home accessibility, and O&P providers. Matt Filippis Named Director of Business Development at VGM thumbnail Matt Filippis Named Director of Business Development at VGM VGM & Associates appoints Matt Filippis as Director of Business Development, Clinical Mobility and Accessibility, supporting CRT, home accessibility, and O&P providers. Matt Filippis Named Director of Business Development at VGM thumbnail Matt Filippis Named Director of Business Development at VGM VGM & Associates appoints Matt Filippis as Director of Business Development, Clinical Mobility and Accessibility, supporting CRT, home accessibility, and O&P providers. Matt Filippis Named Director of Business Development at VGM thumbnail Matt Filippis Named Director of Business Development at VGM VGM & Associates appoints Matt Filippis as Director of Business Development, Clinical Mobility and Accessibility, supporting CRT, home accessibility, and O&P providers. Alternative Sleep Therapies: Guidance for DME Providers thumbnail Alternative Sleep Therapies: Guidance for DME Providers Discover how oral appliance therapy, eXciteOSA, and other alternative sleep therapies are reshaping care in 2026. Alternative Sleep Therapies: Guidance for DME Providers thumbnail Alternative Sleep Therapies: Guidance for DME Providers Discover how oral appliance therapy, eXciteOSA, and other alternative sleep therapies are reshaping care in 2026.